Martin Berghoff

Giessen, HE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Characterization of growth differentiation factor 15 (GDF15) as a neurotropic adipokine permeable to the brain.

Characterization of growth differentiation factor 15 (GDF15) as a neurotropic adipokine permeable to the brain.

Journal: Scientific reports
Published: May 09, 2025

A Cross-Sectional Study: Systematic Quantification of Chemerin in Human Cerebrospinal Fluid.

A Cross-Sectional Study: Systematic Quantification of Chemerin in Human Cerebrospinal Fluid.

Journal: Biomedicines
Published: September 09, 2024

Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis.

Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis.

Journal: British journal of pharmacology
Published: April 25, 2024

The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis.

The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis.

Journal: British journal of pharmacology
Published: November 15, 2022

Is There Reduced Hemodynamic Brain Activation in Multiple Sclerosis Even with Undisturbed Cognition?

Is There Reduced Hemodynamic Brain Activation in Multiple Sclerosis Even with Undisturbed Cognition?

Journal: International journal of molecular sciences
Published: October 31, 2022

Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis.

Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis.

Journal: International journal of molecular sciences
Published: September 05, 2022

Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic.

Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic.

Journal: Journal of neurology
Published: January 03, 2022

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE.

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE.

Journal: International journal of molecular sciences
Published: August 05, 2021

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

Journal: Therapeutic advances in neurological disorders
Published: May 27, 2021

Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)

Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)

Journal: Der Nervenarzt
Published: May 07, 2021

Evidence of a Muscle-Brain Axis by Quantification of the Neurotrophic Myokine METRNL (Meteorin-Like Protein) in Human Cerebrospinal Fluid and Serum.

Evidence of a Muscle-Brain Axis by Quantification of the Neurotrophic Myokine METRNL (Meteorin-Like Protein) in Human Cerebrospinal Fluid and Serum.

Journal: Journal of clinical medicine
Published: April 29, 2021

Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes.

Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes.

Journal: Cells
Published: April 06, 2021
Showing 1-12 of 31

Last Updated: 09/26/2026